{
  "primary": "ATXN3",
  "interaction_type": "direct",
  "upstream_interactor": null,
  "mediator_chain": [],
  "depth": 1,
  "support_summary": "ATXN3 interacts with the E3 ubiquitin ligase Parkin (PRKN), counteracting its auto-ubiquitination and thereby inhibiting its E3 ligase activity. This regulation impacts processes like mitophagy and protein quality control.",
  "functions": [
    {
      "function": "Parkin E3 Ligase Activity",
      "arrow": "inhibits",
      "cellular_process": "ATXN3 directly interacts with the E3 ubiquitin ligase Parkin (PRKN) and deubiquitinates it. This action counteracts Parkin's self-ubiquitination, which is essential for its full E3 ligase activity.",
      "effect_description": "Parkin's E3 ubiquitin ligase activity is inhibited, reducing its ability to ubiquitinate target proteins and itself.",
      "biological_consequence": [
        "ATXN3 binds to PRKN (Parkin) → ATXN3 removes ubiquitin chains from Parkin → Parkin self-ubiquitination is counteracted → Parkin E3 ligase activity is inhibited → Mitophagy initiation is suppressed",
        "PolyQ-expanded ATXN3 exhibits increased activity towards Parkin → Parkin is excessively deubiquitinated → Destabilized Parkin is targeted for autophagic clearance → Cellular Parkin levels are depleted"
      ],
      "specific_effects": [
        "ATXN3 counteracts Parkin self-ubiquitination.",
        "ATXN3 deubiquitinates Parkin directly.",
        "PolyQ-expanded ATXN3 is more active in deubiquitinating Parkin and promotes its clearance via autophagy.",
        "ATXN3 interferes with the attachment of ubiquitin onto Parkin during conjugation."
      ],
      "evidence": [
        {
          "paper_title": "The Machado-Joseph disease-associated mutant form of ataxin-3 regulates parkin ubiquitination and stability",
          "doi": "10.1093/hmg/ddq452",
          "authors": "Durcan TM, Kontogiannea M, Thorarinsdottir T, Fallon L, Williams AJ, Djarmati A, Fantaneanu T, Paulson HL, Fon EA",
          "journal": "Hum Mol Genet",
          "year": 2011,
          "assay": "Co-Immunoprecipitation, In vitro ubiquitination assay",
          "species": "human",
          "relevant_quote": "The interaction between ataxin-3 and parkin is direct, involves multiple domains and is greatly enhanced by parkin self-ubiquitination. Moreover, ataxin-3 deubiquitinates parkin directly in vitro and in cells.",
          "pmid": "20940148"
        },
        {
          "paper_title": "Ataxin-3 deubiquitination is coupled to Parkin ubiquitination via E2 ubiquitin-conjugating enzyme",
          "doi": "10.1074/jbc.M111.288449",
          "authors": "Durcan TM, Kontogiannea M, Bedard N, Wing SS, Fon EA",
          "journal": "J Biol Chem",
          "year": 2012,
          "assay": "In vitro ubiquitination assay, GST pulldown",
          "species": "human",
          "relevant_quote": "Ataxin-3 was found to counteract parkin self-ubiquitination both in vitro and in cells.",
          "pmid": "22081612"
        },
        {
          "paper_title": "The parkin V380L variant is a genetic modifier of Machado–Joseph disease with impact on mitophagy",
          "doi": "10.1007/s00401-024-02762-6",
          "authors": "Dá F, Gerl L, Nouri V, Doss S, Doss S, Kohl Z, Hübener-Schmid J, Wilke C, Synofzik M, Rattay TW, Riess O, Winkelmann J, Traschütz A, Schöls L",
          "journal": "Acta Neuropathol",
          "year": 2024,
          "assay": "Co-Immunoprecipitation",
          "species": "human",
          "relevant_quote": "The E3 ubiquitin ligase parkin, whose mutations are notoriously associated with juvenile manifestations of Parkinson’s disease, is one of the prime binding partners of ataxin-3...",
          "pmid": "39088078"
        }
      ],
      "interaction_effect": "inhibits",
      "direction": "main_to_primary",
      "interaction_direction": "main_to_primary",
      "pmids": [
        "20940148",
        "22081612",
        "39088078"
      ]
    }
  ],
  "arrow": "inhibits",
  "direction": "primary_to_main",
  "intent": "deubiquitination",
  "mechanism": "ATXN3 directly interacts with the E3 ubiquitin ligase Parkin (PRKN) and deubiquitinates it. This action counteracts Parkin's self-ubiquitination, which is essential for its full E3 ligase activity.",
  "effect": "Parkin's E3 ubiquitin ligase activity is inhibited, reducing its ability to ubiquitinate target proteins and itself.",
  "summary": "ATXN3 inhibits PRKN to modulate parkin e3 ligase activity, ultimately affecting mitophagy initiation is suppressed.",
  "evidence": [
    {
      "paper_title": "The Machado-Joseph disease-associated mutant form of ataxin-3 regulates parkin ubiquitination and stability",
      "doi": "10.1093/hmg/ddq452",
      "authors": "Durcan TM, Kontogiannea M, Thorarinsdottir T, Fallon L, Williams AJ, Djarmati A, Fantaneanu T, Paulson HL, Fon EA",
      "journal": "Hum Mol Genet",
      "year": 2011,
      "assay": "Co-Immunoprecipitation, In vitro ubiquitination assay",
      "species": "human",
      "relevant_quote": "The interaction between ataxin-3 and parkin is direct, involves multiple domains and is greatly enhanced by parkin self-ubiquitination. Moreover, ataxin-3 deubiquitinates parkin directly in vitro and in cells."
    },
    {
      "paper_title": "Ataxin-3 deubiquitination is coupled to Parkin ubiquitination via E2 ubiquitin-conjugating enzyme",
      "doi": "10.1074/jbc.M111.288449",
      "authors": "Durcan TM, Kontogiannea M, Bedard N, Wing SS, Fon EA",
      "journal": "J Biol Chem",
      "year": 2012,
      "assay": "In vitro ubiquitination assay, GST pulldown",
      "species": "human",
      "relevant_quote": "Ataxin-3 was found to counteract parkin self-ubiquitination both in vitro and in cells."
    },
    {
      "paper_title": "The parkin V380L variant is a genetic modifier of Machado–Joseph disease with impact on mitophagy",
      "doi": "10.1007/s00401-024-02762-6",
      "authors": "Dá F, Gerl L, Nouri V, Doss S, Doss S, Kohl Z, Hübener-Schmid J, Wilke C, Synofzik M, Rattay TW, Riess O, Winkelmann J, Traschütz A, Schöls L",
      "journal": "Acta Neuropathol",
      "year": 2024,
      "assay": "Co-Immunoprecipitation",
      "species": "human",
      "relevant_quote": "The E3 ubiquitin ligase parkin, whose mutations are notoriously associated with juvenile manifestations of Parkinson’s disease, is one of the prime binding partners of ataxin-3..."
    }
  ],
  "arrow_notation": "ATXN3 --inhibits--> PRKN:",
  "protein_a": "PRKN",
  "protein_b": "ATXN3",
  "discovered_in_query": "ATXN3",
  "first_discovered": "2025-11-18T20:57:38.894626Z",
  "last_updated": "2025-11-18T20:57:38.894626Z"
}